Last updated 45 days ago

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

400 patients around the world

Available in United States, Spain, Chile, Argentina

Seagen Inc.

13Research sites

400Patients around the world

This study is for people with

Colorectal cancer

Colon cancer

Rectal cancer

Requirements for the patient

From 18 Years

All Gender

Medical requirements

Sites

Hospital Británico de Buenos Aires - CABA

Recruiting

Perdriel 74, CABA, Buenos Aireshttps://www.hospitalbritanico.org.ar/

Centro Médico Privado CEMAIC - Córdoba

Recruiting

Monseñor Pablo Cabrera 2941, Córdobawww.cemaic.com.ar

Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires

Recruiting

Av. Crámer 1180, CABA, Buenos Aires

Instituto Médico de la Fundación Estudios Clínicos - Rosario

Recruiting

Italia 428, Rosario - Santa Fe

Instituto Oncológico de Córdoba IONC - Fundación Richardet Longo

Recruiting

Paraná 560, Córdoba

Hospital Nossa Senhora da Conceição

Recruiting

Av. Francisco Trein, 596 – 2º andar - Bairro: Cristo Redentor - CEP 91350-200 - Porto Alegre

Oncocentro APYS - Valparaíso

Recruiting

Avenida La Marina 1702, Viña del Mar, Valparaíso

Centro de Estudios Clínicos SAGA - CECSAGA

Recruiting

Antonio Varas 517, 7500653 Providencia, Región Metropolitana

Hospital Universitario La Paz

Recruiting

Madrid, 28046

Hospital Universitario 12 de Octubre

Recruiting

Av. de Córdoba, s/n, 28041 Madrid

Hospital Clinic de Barcelona

Recruiting

C. de Villarroel, 170, 08036 Barcelona, Spainhttps://www.clinicbarcelona.org/

Hospital General Universitario Alicante

Recruiting

Alicante, 03010

Hospital Universitario Central de Asturias

Recruiting

Oviedo, 33011

StudyMOUNTAINEER-03

SponsorSeagen Inc.

Study typeInterventional

Conditions

Colorectal cancerColon cancerRectal cancer

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT05253651